Events & Presentations

ASCO Genitourinary Cancers Symposium - San Francisco, CA

Jan 19–21, 2017
12:00 AM

Additional Information

Title: RX3117, An Oral Antimetabolite Nucleoside Shows Activity in Subjects with Pancreatic Cancer. Preliminary Results of Stage 1 of the Phase 1a/2b Study [View Poster]

Remind Me

©2018 by Rexahn Pharmaceuticals, Inc. All rights reserved
Rexahn Pharmaceuticals, Inc. - 15245 Shady Grove Road, Suite 455 - Rockville, MD 20850

Terms of Use
Privacy Policy